Effects of Oral Sildenafil on Mortality in Adults With PAH
Public ClinicalTrials.gov record NCT02060487. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A MULTINATIONAL, MULTICENTER STUDY TO ASSESS THE EFFECTS OF ORAL SILDENAFIL ON MORTALITY IN ADULTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a blinded study in adult patients with PAH evaluating the relative effects of sildenafil on mortality when administered at the three doses (80 mg, 20 mg or 5 mg, all three times per day \[TID\]). In addition, the relative effects on clinical worsening and 6-minute walking distance (6MWD) will be assessed.
Study identification
- NCT ID
- NCT02060487
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 385 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 74 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 22, 2014 (Actual)
- Primary completion
- Feb 26, 2021 (Actual)
- Completion
- Feb 26, 2021 (Actual)
- Last update posted
- May 13, 2022
2014 – 2021
United States locations
- U.S. sites
- 11
- U.S. states
- 5
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Emory University Investigational Drug Services | Atlanta | Georgia | 30322 | — |
| The Emory Clinic | Atlanta | Georgia | 30322 | — |
| Frederik Meijer Heart & Vascular Institute Cardiovascular Research | Grand Rapids | Michigan | 49503 | — |
| Spectrum Health Butterworth Hospital IDS Pharmacy | Grand Rapids | Michigan | 49503 | — |
| Spectrum Health Heart & Lung Specialized Care Clinic | Grand Rapids | Michigan | 49503 | — |
| Spectrum Health Hospitals | Grand Rapids | Michigan | 49503 | — |
| Spectrum Health Medical Group - Pulmonary Division | Grand Rapids | Michigan | 49546 | — |
| Spectrum Health | Grand Rapids | Michigan | 49546 | — |
| Robert V. Sibilia MD, Inc. | Wooster | Ohio | 44691 | — |
| UT Southwestern Medical School | Dallas | Texas | 75390-8550 | — |
| Aurora St. Luke's Medical Center | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 71 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02060487, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 13, 2022 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02060487 live on ClinicalTrials.gov.